The Cerebellum

, Volume 11, Issue 1, pp 50–61 | Cite as

Role of Nitric Oxide in Cerebellar Development and Function: Focus on Granule Neurons



More than 20 years of research have firmly established important roles of the diffusible messenger molecule, nitric oxide (NO), in cerebellar development and function. Granule neurons are main players in every NO-related mechanism involving cerebellar function and dysfunction. Granule neurons are endowed with remarkable amounts of the Ca2+-dependent neuronal isoform of nitric oxide synthase and can directly respond to endogenously produced NO or induce responses in neighboring cells taking advantage of the high diffusibility of the molecule. Nitric oxide acts as a negative regulator of granule cell precursor proliferation and promotes survival and differentiation of these neurons. Nitric oxide is neuroprotective towards granule neurons challenged with toxic insults. Nitric oxide is a main regulator of bidirectional plasticity at parallel fiber-Purkinje neuron synapses, inducing long-term depression (LTD) or long-term potentiation (LTP) depending on postsynaptic Ca2+ levels, thus playing a central role in cerebellar learning related to motor control. Granule neurons cooperate with glial cells, in particular with microglia, in the regulation of NO production through the respective forms of NOS present in the two cellular types. Aim of the present paper is to review the state of the art and the improvement of our understanding of NO functions in cerebellar granule neurons obtained during the last two decades and to outline possible future development of the research.


Nitric oxide cGMP signaling Cerebellar granule neurons Neurogenesis Survival and differentiation Synaptic plasticity Glial cell interactions 


  1. 1.
    Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265–9.PubMedGoogle Scholar
  2. 2.
    Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524–6.PubMedGoogle Scholar
  3. 3.
    Ignarro LJ. Nitric oxide in the regulation of vascular function: an historical overview. J Card Surg. 2002;17:301–6.PubMedGoogle Scholar
  4. 4.
    Murad F. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med. 2006;355:2003–11.PubMedGoogle Scholar
  5. 5.
    Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggest role as intercellular messenger in the brain. Nature. 1988;336:385–8.PubMedGoogle Scholar
  6. 6.
    Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol. 1995;57:683–706.PubMedGoogle Scholar
  7. 7.
    Dawson TM, Sasaki M, Gonzalez-Zulueta J, Dawson VL. Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathways. Progr Brain Res. 1998;118:3–11.Google Scholar
  8. 8.
    Contestabile A. Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res Rev. 2000;32:476–509.PubMedGoogle Scholar
  9. 9.
    Guix FX, Uribesalgo M, Coma M, Munoz FJ. The physiology and pathophysiology of nitric oxide in the brain. Progr Neurobiol. 2005;76:126–52.Google Scholar
  10. 10.
    Contestabile A. Regulation of transcription factors by nitric oxide in neurons and in neural-derived tumor cells. Progr Neurobiol. 2008;84:317–28.Google Scholar
  11. 11.
    Garthwaite J. Concept of neural nitric oxide-mediated transmission. Eur J Neurosci. 2008;27:2783–802.PubMedGoogle Scholar
  12. 12.
    Garthwaite J. Dynamics of cellular NO-cGMP signaling. Front Biosci. 2005;10:1868–80.PubMedGoogle Scholar
  13. 13.
    Hall CN, Garthwaite J. Inactivation of nitric oxide by ray cerebellar slices. J Physiol. 2006;577:549–67.PubMedGoogle Scholar
  14. 14.
    Hall CN, Garthwaite J. What is the real physiological NO concentration in vivo? Nitric Oxide. 2009;21:92–103.PubMedGoogle Scholar
  15. 15.
    Lancaster Jr JR. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide. 1997;1:18–30.PubMedGoogle Scholar
  16. 16.
    Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, et al. Interaction of nitric oxide synthase with the postsynaptic density protein PDS-95 and alpha1-syntrophin mediated by PDZ domains. Cell. 1996;84:757–67.PubMedGoogle Scholar
  17. 17.
    Brenman JE, Bredt DS. Synaptic signaling by nitric oxide. Curr Opin Neurobiol. 1997;7:374–8.PubMedGoogle Scholar
  18. 18.
    Ihara H, Kuwamura M, Atsuta M, Nihonmastu I, Okada T, Mukamoto M, et al. Expression of neuronal nitric oxide synthase variant, nNOS-μ, in rat brain. Nitric Oxide. 2006;15:13–9.PubMedGoogle Scholar
  19. 19.
    Campese VM, Sindhu RK, Ye S, Bay Y, Vaziri ND, Jabbari B. Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain. Brain Res. 2007;1134:27–32.PubMedGoogle Scholar
  20. 20.
    Rodrigo J, Alonso D, Fernandez AP, Serrano J, Richart A, Lopez JC, et al. Neuronal and inducible nitric oxide synthase expression and protein nitration in rat cerebellum after oxygen and glucose deprivation. Brain Res. 2001;909:20–45.PubMedGoogle Scholar
  21. 21.
    Suarez I, Bodega G, Rubio M, Felipo V, Fernandez B. Neuronal and inducible nitric oxide synthase expression in the rat cerebellum following portacaval anastomosis. Brain Res. 2005;1047:205–13.PubMedGoogle Scholar
  22. 22.
    Vincent SR. Nitric oxide neurons and neurotransmission. Progr Neurobiol. 2010;90:246–55.Google Scholar
  23. 23.
    Vincent SR, Kimura H. Histochemical mapping of nitric oxyde synthase in the rat brain. Neuroscience. 1992;46:755–84.PubMedGoogle Scholar
  24. 24.
    Rodrigo J, Springall DR, Uttenthal O, Bentura MI, Abadia-Molina F, Riveros-Moreno V, et al. Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond B Biol Sci. 1994;345:175–221.PubMedGoogle Scholar
  25. 25.
    Schilling K, Schmidt HW, Baader SL. Nitric oxyde synthase expression reveals compartments of cerebellar granule cells and suggests a role for mossy fibers in their development. Neuroscience. 1994;59:893–903.PubMedGoogle Scholar
  26. 26.
    Ciani E, Calvanese V, Crochemore C, Bartesaghi R, Contestabile A. Proliferation of cerebellar precursor cells is negatively regulated by nitric oxide in the newborn rat. J Cell Sci. 2006;119:3161–70.PubMedGoogle Scholar
  27. 27.
    Virgili M, Monti B, Lo Russo A, Bentivogli M, Contestabile A. Developmental effects of in vivo and in vitro inhibition of nitric oxide synthase in neurons. Brain Res. 1999;839:164–72.PubMedGoogle Scholar
  28. 28.
    Wang W, Nakayama T, Inoue N, Kato T. Quantitative analysis of nitric oxide synthase expressed in the developing and differentiating rat cerebellum. Devel Brain Res. 1998;111:65–75.Google Scholar
  29. 29.
    Contestabile A. Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. Cerebellum. 2002;1:41–55.PubMedGoogle Scholar
  30. 30.
    Ciani E, Virgili M, Contestabile A. Akt pathway mediates a cGMP-dependent survival role of nitric oxide in cerebellar granule neurons. J Neurochem. 2002;81:218–28.PubMedGoogle Scholar
  31. 31.
    Li M, Wang L, Peng Y, Wang J-C, Zhou L-H. Knockdown of the neuronal nitric oxide synthase gene retard the development of cerebellar granule neurons in vitro. Devel Dyn. 2010;239:474–81.Google Scholar
  32. 32.
    Mulero-Navarro S, Santiago-Josefa B, Pozo-Guisado E, Merino JM, Fernandez-Salguero PM. Down-regulation of CYP1A2 induction during the maturation of mouse cerebellar granule cells in culture: role of nitric oxide accumulation. Eur J Neurosci. 2003;18:2265–72.PubMedGoogle Scholar
  33. 33.
    Krainock R, Murphy S. Regulation of functional nitric oxide synthase-1 expression in cerebellar granule neurons by heregulin is post-transcriptional and involves mitogen-activated protein kinase. J Neurochem. 2001;78:552–9.PubMedGoogle Scholar
  34. 34.
    Wykes V, Bellamy TC, Garthwaite J. Membrane association and the sensitivity of guanylyl cyclase-coupled receptors to nitric oxide. Br J Pharmacol. 2004;141:1087–90.PubMedGoogle Scholar
  35. 35.
    Martin E, Berka V, Bogatenkova E, Murad F, Tsai AL. Ligand selectivity of soluble guanylyl cyclase: effect of hydrogen-bonding tyrosine in the distal heme pocket on binding of oxygen, nitric oxide and carbon monoxide. J Biol Chem. 2006;281:27836–45.PubMedGoogle Scholar
  36. 36.
    Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic guanosine monophosphate levels in various tissue preparation. Proc Natl Acad Sci USA. 1977;74:3203–7.PubMedGoogle Scholar
  37. 37.
    Ding JD, Burette A, Nedvetsky PI, Schmidt HH, Weinberg RJ. Distribution of soluble guanylyl cyclase in the rat brain. J Comp Neurol. 2004;472:437–48.PubMedGoogle Scholar
  38. 38.
    Zabel U, Kleinschnitz C, Oh P, Nedvetsky P, Smolenski A, Muller H, et al. Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat Cell Biol. 2002;4:307–11.PubMedGoogle Scholar
  39. 39.
    Jones JD, Camey ST, Vrana KE, Norford DC, Howlett AC. Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells. Neuropharmacology. 2008;54:23–30.PubMedGoogle Scholar
  40. 40.
    Russwurm M, Wittau N, Koesling D. Guanylyl cyclase/PSD95 interaction: targeting of the NO-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes. J Biol Chem. 2001;276:44647–52.PubMedGoogle Scholar
  41. 41.
    Bellamy TC, Garthwaite J. Sub-second kinetics of the nitric oxide recptor, soluble guanylyl cyclase, in intact cerebellar cells. J Biol Chem. 2001;276:4287–92.PubMedGoogle Scholar
  42. 42.
    Mo E, Amin H, Bianco IH, Garthwaite J. Kinetics of cellular nitric oxide/cGMP/phosphodiesterase-5 pathway. J Biol Chem. 2004;279:24149–58.Google Scholar
  43. 43.
    Roy B, Garthwaite J. Nitric oxide activation of guanylyl cyclase in cells revisited. Proc Natl Acad Sci USA. 2006;103:12185–90.PubMedGoogle Scholar
  44. 44.
    Kaupp UB, Seifert R. Cyclic nucleotide-gated ion channels. Physiol Rev. 2002;82:769–824.PubMedGoogle Scholar
  45. 45.
    Craven KB, Zagotta WN. CNG and HCN channels: two peas, one pod. Annu Rev Physiol. 2006;68:375–401.PubMedGoogle Scholar
  46. 46.
    Feil R, Hofmann F, Kleppisck T. Function of cGMP-dependent protein kinases in the nervous system. Rev Neurosci. 2005;16:23–41.PubMedGoogle Scholar
  47. 47.
    Schlossmann J, Hofmann F. cGMP-dependent protein kinases in drug discovery. Drug Discov Today. 2006;10:627–34.Google Scholar
  48. 48.
    Hofmann F, Feil F, Kleppisck T, Schlossmann J. Function of cAMP-dependent protein kinases as revealed by gene deletion. Physiol Rev. 2006;86:1–23.PubMedGoogle Scholar
  49. 49.
    Koppenol WH. NO nomenclature? Nitric Oxide. 2002;6:96–8.PubMedGoogle Scholar
  50. 50.
    Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994;78:931–6.PubMedGoogle Scholar
  51. 51.
    Kelm M, Dahamann R, Wink D, Feelisch M. The nitric oxide/superoxide assay. Insights into the biological chemistry of the NO/O2 interaction. J Biol Chem. 1997;272:9922–32.PubMedGoogle Scholar
  52. 52.
    Hanafy KA, Krumenacker JS, Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit. 2001;7:801–19.PubMedGoogle Scholar
  53. 53.
    Jaffrey SM, Erdjument-Bromage H, Ferris CD, Tempts P, Snyder SH. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol. 2001;3:193–7.PubMedGoogle Scholar
  54. 54.
    Riccio A, Alvania RS, Lonze BE, Ramanan N, Kim T, Huang Y, et al. A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell. 2006;21:283–94.PubMedGoogle Scholar
  55. 55.
    Walton MR, Dragunow M. Is CREB a key to neuronal survival? Trends Neurosci. 2000;23:48–53.PubMedGoogle Scholar
  56. 56.
    Carlezon WA, Dumas RS, Nestler EJ. The many faces of CREB. Trends Neurosci. 2005;28:436–45.PubMedGoogle Scholar
  57. 57.
    Nott A, Watson PM, Robinson JD, Crepaldi L, Riccio A. S-nitrosylation of histone deacetylase 2 induces chromatin remodeling in neurons. Nature. 2008;455:411–6.PubMedGoogle Scholar
  58. 58.
    Nott A, Riccio A. Nitric oxide-mediated epigenetic mechanisms in developing neurons. Cell Cycle. 2009;8:1–6.Google Scholar
  59. 59.
    Ciani E, Guidi S, Bartesaghi R, Contestabile A. Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide. J Neurochem. 2002;82:1282–9.PubMedGoogle Scholar
  60. 60.
    Duport S, Garthwaite J. Pathological consequences of inducible nitric oxide synthase expression in hippocampal slice cultures. Neuroscience. 2005;135:1155–66.PubMedGoogle Scholar
  61. 61.
    Erusalimsky JD, Moncada S. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler Thromb Vasc Biol. 2007;27:2467–72.Google Scholar
  62. 62.
    Villalobo A. Nitric oxide and cell proliferation. FEBS J. 2006;273:2329–44.PubMedGoogle Scholar
  63. 63.
    Peña-Altamira E, Petazzi P, Contestabile A. Nitric oxide control of proliferation in nerve cells and in tumor cells of nervous origin. Curr Pharmaceut Des. 2010;16:440–50.Google Scholar
  64. 64.
    Peunova N, Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature. 1995;375:68–73.PubMedGoogle Scholar
  65. 65.
    Champlin DT, Truman JW. Ecdysteroid coordinates optic lobe neurogenesis via a nitric oxide signaling pathway. Development. 2000;127:3543–51.PubMedGoogle Scholar
  66. 66.
    Kuzin B, Regulski M, Stasiv Y, Scheinker V, Tully T, Enikolopov G. Nitric oxide interacts with retinoblastoma pathway to control eye development in Drosophila. Curr Biol. 2000;10:459–62.PubMedGoogle Scholar
  67. 67.
    Peunova N, Scheinker V, Cline H, Enikolopov G. Nitric oxide is an essential negative regulator of cell proliferation in Xenopus brain. J Neurosci. 2001;21:8809–18.PubMedGoogle Scholar
  68. 68.
    Traister A, Abashidze S, Gold V, Placata N, Karchovsky E, Patel K, et al. Evidence that nitric oxide regulates cell cycle progression and cell death in the developing neural tube. Exp Cell Res. 2002;288:354–62.Google Scholar
  69. 69.
    Traister A, Abashidze S, Gold V, Yairi R, Michael E, Placata N, et al. BMP controls nitric oxide-mediated regulation of cell numbers in the developing neural tube. Cell Death Differ. 2004;11:832–41.PubMedGoogle Scholar
  70. 70.
    Packer MA, Stasiv Y, Benraiss A, Chmielniki E, Grinberg A, Westphal H, et al. Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci USA. 2003;100:9566–71.PubMedGoogle Scholar
  71. 71.
    Moreno-lopez B, Romero-Grimaldi C, Noval JA, Murillo-Carretero M, Matarredona ER, Estrada C. Nitric oxide is a physiological inhibitor of neurogenesis in the adult mouse subventricular zone and olfactory bulb. J Neurosci. 2004;24:85–95.PubMedGoogle Scholar
  72. 72.
    Zhu XJ, Hua Y, Jiang J, Zhou QG, Luo CX, Han X, et al. Neuronal nitric oxide synthase-derived nitric oxide inhibits neurogenesis in the adult dentate gyrus by down-regulating cyclic AMP response binding protein phosphorylation. Neuroscience. 2006;141:827–36.PubMedGoogle Scholar
  73. 73.
    Torroglosa A, Murillo-Carretero M, Romero-Grimaldi C, Matarredona ER, Campos-Caro A, Estrada C. Nitric oxide decreases subventricular zone stem cell proliferation by inhibition of epidermal growth factor receptor and phosphoinositide-3-kinase/Akt pathway. Stem Cells. 2007;25:88–97.PubMedGoogle Scholar
  74. 74.
    Tanaka M, Yoshida S, Yano M, Hanaoka F. Roles of endogenous nitric oxide in cerebellar cortical development in slice cultures. NeuroReport. 1994;5:2049–52.PubMedGoogle Scholar
  75. 75.
    Ciani E, Severi S, Contestabile A, Bartesaghi R, Contestabile A. Nitric oxide negatively regulates proliferation and promotes neuronal differentiation through N-Myc downregulation. J Cell Sci. 2004;117:4727–37.PubMedGoogle Scholar
  76. 76.
    Vaillant C, Monard D. SHH pathway and cerebellar development. Cerebellum. 2009;8:291–301.PubMedGoogle Scholar
  77. 77.
    Kenney AM, Cole MD, Rowitch DH. N-Myc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development. 2003;130:15–28.PubMedGoogle Scholar
  78. 78.
    Knoepfler PS, Kenney AM. Neural precursor cycling at sonic speed. N-Myc pedals, GSK-3 brakes. Cell Cycle. 2006;5:47–52.PubMedGoogle Scholar
  79. 79.
    Knoepfler PS, Cheng PF, Eisenman RN. N.Myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Devel. 2002;16:2699–712.PubMedGoogle Scholar
  80. 80.
    Marino S. Medulloblastoma: developmental mechanisms out of control. Trends Mol Med. 2005;11:17–22.PubMedGoogle Scholar
  81. 81.
    Kessler JD, Hasegawa H, Brun SN, Emmenegger BA, Yang ZJ, Dutton JW, et al. N-Myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma. Genes Devel. 2009;23:157–70.PubMedGoogle Scholar
  82. 82.
    Hatton BA, Knoepfler PS, Kenney AM, Rowitch DH, Moreno de Alboran I, Olson JM, et al. N-Myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. Cancer Res. 2006;66:8655–61.PubMedGoogle Scholar
  83. 83.
    Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 1993;75:1273–86.PubMedGoogle Scholar
  84. 84.
    Huang PL, Fishman MC. Genetic analysis of nitric oxide synthase isoforms: targeted mutation in mice. J Mol Med. 1996;74:415–21.PubMedGoogle Scholar
  85. 85.
    Romero-Grimaldi C, Moreno-Lopez B, Estrada C. Age-dependent effect of nitric oxide on subventricular zone and olfactory bulb neural precursor proliferation. J Comp Neurol. 2008;506:339–46.PubMedGoogle Scholar
  86. 86.
    Snyder SH. Janus faces off nitric oxide. Nature. 1993;364:577.PubMedGoogle Scholar
  87. 87.
    Dawson TM, Dawson VL. Nitric oxide: actions and pathological roles. Neuroscientist. 1995;1:7–18.Google Scholar
  88. 88.
    Contestabile A, Ciani E. Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. Neurochem Int. 2004;45:903–14.PubMedGoogle Scholar
  89. 89.
    Blaise G, Gauvin D, Authier S. Nitric oxide, cell signaling and cell death. Toxicology. 2005;208:177–92.PubMedGoogle Scholar
  90. 90.
    Boje KM, Arora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 1992;587:250–6.PubMedGoogle Scholar
  91. 91.
    Leist M, Fava E, Montecucco C, Nicotera P. Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur J Neurosci. 1997;9:1488–98.PubMedGoogle Scholar
  92. 92.
    Lin S, Zhang Y, Dodel R, Farlow M, Paul SM, Du Y. Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in cerebellar granule neurons. Neurosci Lett. 2001;315:61–4.PubMedGoogle Scholar
  93. 93.
    He J, Kang H, Yan F, Chen C. The endoplasmic reticulum-related events in S-nitrosoglutathione-induced neurotoxicity in cerebellar granule cells. Brain Res. 2004;1015(1–2):25–33.PubMedGoogle Scholar
  94. 94.
    Mander P, Borutaite V, Moncada S, Brown GC. Nitric oxide from inflammatory-activated glia synergize with hypoxia to induce neuronal death. J Neurosci Res. 2005;79:208–15.PubMedGoogle Scholar
  95. 95.
    Scorziello A, Pellegrini C, Secondo A, Sirabella R, Formisano L, Sibaud L, et al. Neuronal NOS activation during oxygen and glucose deprivation triggers cerebella granule cell death in the later reoxygenation phase. J Neurosci Res. 2005;76:812–21.Google Scholar
  96. 96.
    Fatokun AA, Stone TW, Smith RA. Prolonged exposure of cerebella granule neurons to S-nitroso-N-acetylpenicillamine (SNAP) induce neuronal damage independently of peroxynitrite. Brain Res. 2008;1230:265–72.PubMedGoogle Scholar
  97. 97.
    Viani P, Giussani P, Riboni L, Bassi R, Tettamanti G. Behaviour of nitric oxide synthase in rat cerebellar granule cells differentiating in culture. FEBS Lett. 1997;408:131–4.PubMedGoogle Scholar
  98. 98.
    Bonthius DJ, Karacay B, Dai D, Hutton A, Pantazis NJ. The NO-cGMP-PKG pathwayplays an essential role in the acquisition of ethanol resistance by cerebellar granule neurons. Neurotoxicol Teratol. 2004;26:47–57.PubMedGoogle Scholar
  99. 99.
    Bonthius DJ, Bonthius NE, Li S, Karacay B. The protective effect of neuronal nitric oxide synthase (nNOS) against alcohol toxicity depends upon the NO-cGMP-PKG pathway and NF-κB. Neurotoxicology. 2008;29:1080–91.PubMedGoogle Scholar
  100. 100.
    Bonthius DJ, Tzouras G, Karacay B, Mahoney J, Hutton A, McKim R, et al. Deficiency of neuronal nitric oxide synthase (nNOS) worsens alcohol-induced microencephaly and neuronal loss in developing mice. Devel Brain Res. 2002;138:45–59.Google Scholar
  101. 101.
    Pantazis NJ, West JR, Dai D. The nitric oxide-cyclic GMP pathway plays an essential role in both promoting cell survival of cerebellar granule cells in culture and protecting the cells against ethanol neurotoxicity. J Neurochem. 1998;70:1826–38.PubMedGoogle Scholar
  102. 102.
    Bonthius DJ, Karacay B, Dai D, Pantazis NJ. FGF-2, NGF and IGF-1, but not BDNF, utilize a nitric oxide pathway to signal neurotrophic and neuroprotective effects against alcohol toxicity in cerebellar granule cell cultures. Devel Brain Res. 2003;140:15–28.Google Scholar
  103. 103.
    Karacay B, Li G, Pantazis NJ, Bonthius DJ. Stimulation of the cAMP pathway protects cultured cerebellar granule neurons against alcohol-induced cell death by activating the neuronal nitric oxide synthase (nNOS) gene. Brain Res. 2007;1143:34–45.PubMedGoogle Scholar
  104. 104.
    Li CY, Chin TY, Chueh SH. Rat cerebellar granule cells are protected from glutamate-induced excitotoxicity by S-nitrosoglutathione but not glutathione. Am J Physiol Cell Physiol. 2004;286:893–904.Google Scholar
  105. 105.
    Vieria HL, Queiroga CS, Alves PM. Pre-conditioning induced by carbon monoxide provides neuronal protection against apoptosis. J Neurochem. 2008;107:375–84.Google Scholar
  106. 106.
    Feil R, Kleppisch T. NO/cGMP-dependent modulation of synaptic transmission. Handb Exp Pharmacol. 2008;184:529–60.PubMedGoogle Scholar
  107. 107.
    Kleppisch T, Feil R. cGMP signaling in the mammalian brain: role in synaptic plasticity and behaviour. Handb Exp Pharmacol. 2009;191:549–79.PubMedGoogle Scholar
  108. 108.
    Ito M. Cerebellar long-term depression: characterization, signal transduction and functional roles. Physiol Rev. 2001;81:1143–95.PubMedGoogle Scholar
  109. 109.
    Hartell NA. Parallel fiber plasticity. Cerebellum. 2002;1:3–18.PubMedGoogle Scholar
  110. 110.
    Shibuki K, Okada D. Endogenous nitric oxide release required for long-term depression in the cerebellum. Nature. 1991;349:326–8.PubMedGoogle Scholar
  111. 111.
    Linden DJ, Connor JA. Long-term depression of glutamate currents in cultured cerebellar Purkinje neurons does not require nitric oxide signaling. Eur J Neurosci. 1992;4:10–5.PubMedGoogle Scholar
  112. 112.
    Daniel H, Hemart N, Jaillard D, Crepel F. Long-term depression requires nitric oxide and guanosine 3′, 5′ cyclic monophosphate production in rat cerebellar Purkinje cells. Eur J Neurosci. 1993;5:1079–82.PubMedGoogle Scholar
  113. 113.
    Crepel F, Audinat E, Daniel H, Jaillard D, Rossier J, Lambolez B. Cellular locus of the nitric oxide synthase involved in cerebellar long-term depression induced by high external potassium concentration. Neuropharmacology. 1994;33:1399–405.PubMedGoogle Scholar
  114. 114.
    Hartell NA. cGMP acts within cerebellar Purkinje cells to produce long term depression via mechanisms involving PKC and PKG. NeuroReport. 1994;21:833–6.Google Scholar
  115. 115.
    Linden DJ, Connor JA. Long-term synaptic depression. Annu Rev Neurosci. 1994;18:319–57.Google Scholar
  116. 116.
    Lev-Ram V, Makings LR, Keitz PF, Kao JPY, Tsien RY. Long-term depression in cerebellar Purkinje neurons results from coincidence of nitric oxide and depolarization-induced Ca2+ transients. Neuron. 1995;15:407–15.PubMedGoogle Scholar
  117. 117.
    Shibuki K, Kimura S. Dynamic properties of nitric oxide release from parallel fibres in rat cerebellar slices. J Physiol. 1997;498:443–52.PubMedGoogle Scholar
  118. 118.
    Shin JH, Linden DJ. An NMDA receptor/nitric oxide cascade is involved in cerebellar LTD but is not localized to the parallel fiber terminal. J Neurophysiol. 2005;94:4281–9.PubMedGoogle Scholar
  119. 119.
    Launey T, Endo S, Sakai R, Harano J, Ito M. Protein phosphatase 2A inhibition induces cerebellar long-term depression and declustering of synaptic AMPA receptors. Proc Natl Acad Sci USA. 2004;101:676–81.PubMedGoogle Scholar
  120. 120.
    Lev-Ram V, Jiang T, Wood J, Lawrence DS, Tsien RY. Sinergies and coincidence requirements between NO, cGMP and Ca2+ in the induction of cerebellar long-term depression. Neuron. 1997;18:1025–38.PubMedGoogle Scholar
  121. 121.
    Casado M, Dieudonné S, Ascher P. Presynaptic N-methyl-d-aspartate receptors at the parallel fiber-Purkinje cell synapses. Proc Natl Acad Sci USA. 2000;97:11593–7.PubMedGoogle Scholar
  122. 122.
    Ogasawara H, Doi T, Doya K, Kawato M. Nitric oxide regulates input specificity of long-term depression and context dependence of cerebellar learning. PLoS Comp Biol. 2007;3:49–58.Google Scholar
  123. 123.
    Schweighofer N, Ferriol G. Diffusion of nitric oxide can facilitate cerebellar learning: a simulation study. Proc Natl Acad Sci USA. 2000;97:10661–5.PubMedGoogle Scholar
  124. 124.
    Lev-Ram V, Metha SB, Kleinfeld D, Tsien RY. A new form of cerebellar long-term potentiation is postsynaptic and depends on nitric oxide but not cAMP. Proc Natl Acad Sci USA. 2002;99:8389–93.PubMedGoogle Scholar
  125. 125.
    Lev-Ram V, Metha SB, Kleinfeld D, Tsien RY. Reversing cerebellar long-term depression. Proc Natl Acad Sci USA. 2003;100:15989–93.PubMedGoogle Scholar
  126. 126.
    Coesmans M, Weber JT, DeZeeuw CI, Hansel C. Bidirectional parallel fiber plasticity in the cerebellum under climbing fiber control. Neuron. 2004;44:691–700.PubMedGoogle Scholar
  127. 127.
    Salin PA, Malenka RC, Nicoll RA. Cyclic AMP mediates a presynaptic form of LTP at cerebellar parallel fiber synapses. Neuron. 1996;15:675–88.Google Scholar
  128. 128.
    Storm DR, Hansel C, Hacker B, Parent A, Linden DJ. Impaired cerebellar long-term potentiation in type I adenylyl cyclase mutant mice. Neuron. 1998;20:1199–210.PubMedGoogle Scholar
  129. 129.
    Lonart G, Schoch S, Kaeser PS, Larkin CI, Sudhof TC, Linden DJ. Phosphorylation of RIM1alpha by PKA triggers presynaptic long-term potentiation at cerebellar parallel fiber synapses. Cell. 2003;115:49–60.PubMedGoogle Scholar
  130. 130.
    Jacoby S, Sims RE, Hartell NA. Nitric oxide is required for the induction and heterosynaptic spread of long-term potentiation in rat cerebellar slices. J Physiol Lond. 2001;535:825–39.PubMedGoogle Scholar
  131. 131.
    Qiu D-L, Knopfel T. An NMDA receptor/nitric oxide cascade in presynaptic parallel fiber-Purkinje neuron long-term potentiation. J Neurosci. 2007;27:3408–15.PubMedGoogle Scholar
  132. 132.
    D’Angelo E, Rossi P, Armano S, Taglietti V. Evidence for NMDA and mGlu receptor-dependent long-term potentiation of mossy fiber-granule cell transmission in rat cerebellum. J Neurophysiol. 1999;81:277–87.PubMedGoogle Scholar
  133. 133.
    Armano S, Rossi P, Taglietti V, D’Angelo E. Long-term potentiation of intrinsic excitability at the mossy fiber-granule cell synapses of rat cerebellum. J Neurosci. 2000;15:5208–16.Google Scholar
  134. 134.
    Maffei A, Prestori F, Rossi P, Taglietti V, D'Angelo E. Presynaptic current changes at the mossy fiber-granule cell synapse of cerebellum during LTP. J Neurophysiol. 2001;88:627–38.Google Scholar
  135. 135.
    Maffei A, Prestori F, Shibuki K, Rossi P, Taglietti V, D’Angelo E. NO enhances presynaptic currents during cerebellar mossy fiber-granule cell LTP. J Neurophysiol. 2003;90:2478–83.PubMedGoogle Scholar
  136. 136.
    Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH. Central and systemic endotoxin challenge exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci. 2005;25:9275–84.PubMedGoogle Scholar
  137. 137.
    Moncada S, Bolanos JP. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem. 2006;97:1676–89.PubMedGoogle Scholar
  138. 138.
    Willmott NJ, Wong K, Strong AJ. A fundamental role for the nitric oxide-G kinase signaling pathway in mediating intercellular Ca2+ waves in glia. J Neurosci. 2000;20:1767–79.PubMedGoogle Scholar
  139. 139.
    Matyash V, Filippov V, Mohrhagen K, Kettenmann H. Nitric oxide signals parallel fiber activity to Bergmann glial cells in the mouse cerebellar slices. Mol Cell Neurosci. 2001;18:664–70.PubMedGoogle Scholar
  140. 140.
    Bonfoco E, Leist M, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P. Cytoskeletal breakdown and apoptosis elicited by NO donors in cerebellar granule cells require NMDA receptor activation. J Neurochem. 1996;67:2484–93.PubMedGoogle Scholar
  141. 141.
    Kim WK, Ko KH. Potentiation of N-methyl-d-aspartate-mediated neurotoxicity by immunostimulated murine microglia. J Neurosci Res. 1998;54:17–26.PubMedGoogle Scholar
  142. 142.
    Kim WK, Seo DO, Choi JJ, Ko KH. Immunostimulated glial cells potentiate glucose deprivation-induced death of cultured rat cerebellar granule cells. J Neurotrauma. 1999;16:415–24.PubMedGoogle Scholar
  143. 143.
    Schwartz M, Kipnis J. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J Neurol Sci. 2005;233:163–6.PubMedGoogle Scholar
  144. 144.
    Butovsky O, Koronyo-Hamaoui M, Kunis G, Ophir E, Landa G, Cohen H, et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci USA. 2006;103:11784–9.PubMedGoogle Scholar
  145. 145.
    Schwartz M, Ziv Y. Immunity to self and self-maintenance: a unified theory of brain pathologies. Trends Immunol. 2008;29:211–9.PubMedGoogle Scholar
  146. 146.
    Cameron B, Landreth GE. Inflammation, microglia and Alzheimer's disease. Neurobiol Dis. 2010;37:503–9.PubMedGoogle Scholar
  147. 147.
    Polazzi E, Monti B. Microglia and neuroprotection: from in vitro studies to therapeutic applications. Progr Neurobiol. 2010;in press.Google Scholar
  148. 148.
    Polazzi E, Contestabile A. Reciprocal interactions between microglia and neurons from survival to neuropathology. Rev Neurosci. 2002;13:221–42.PubMedGoogle Scholar
  149. 149.
    Polazzi E, Contestabile A. Neuron-conditioned media differentially affect the survival of activated or unstimulated microglia: evidence for neuronal control on apoptotic elimination of activated microglia. J Neuropath Exp Neurol. 2003;62:351–62.PubMedGoogle Scholar
  150. 150.
    Polazzi E, Contestabile A. Overactivation of LPS-stimulated microglial cells by co-cultured neurons or neuron-conditioned medium. J Neuroimmunol. 2006;172:104–11.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of BiologyUniversity of BolognaBolognaItaly

Personalised recommendations